Cash flow Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 16/01/2026 GMT			5-day change	1st Jan Change
7.470 ^USD	+0.27%		+1.91%	-15.31%

01-15	Vanda Pharmaceuticals Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-15-2026 09:00 AM
01-08	Wall Street Wavers Amid Trump's Defense Budget Plans, Driving Muted Premarket Action for US Equity Futures	MT

8a3d6fa054a12fcf9fd1debbd12.urKqsmqRIg5qwMuAM4J4XPhEfOi8hSqxDejm-uC_BmE.6sHQ1xvVW2ZSs6z0Ve0OP6oqLb7F7kz3Zpykk6aLYw_J0enxHvVOYSiQkg

Published financial data: VANDA PHARMACEUTICALS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	248M	269M	254M	193M	199M
Total Revenues	248M	269M	254M	193M	199M
Cost of Goods Sold, Total	23.36M	25.63M	24.28M	14.8M	11.31M
Gross Profit	225M	243M	230M	178M	187M
Selling General & Admin Expenses, Total	141M	124M	136M	113M	146M
R&D Expenses	55.58M	75.36M	85.77M	76.82M	74.43M
Amortization of Goodwill and Intangible Assets - (IS)	1.48M	1.48M	1.52M	2.09M	7.27M
Other Operating Expenses, Total	198M	201M	224M	192M	228M
Operating Income	27.24M	42.16M	6.33M	-13.95M	-40.66M
Interest And Investment Income	4.42M	199K	4.97M	-	-
Net Interest Expenses	4.42M	199K	4.97M	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-	-	-	11.49M	10.74M
EBT, Excl. Unusual Items	31.66M	42.36M	11.3M	-2.46M	-29.92M
Gain (Loss) On Sale Of Investments	-	-	-	8.8M	6.99M
EBT, Incl. Unusual Items	31.66M	42.36M	11.3M	6.34M	-22.92M
Income Tax Expense	8.32M	9.21M	5.02M	3.83M	-4.02M
Earnings From Continuing Operations	23.34M	33.15M	6.28M	2.51M	-18.9M
Net Income to Company	23.34M	33.15M	6.28M	2.51M	-18.9M
Net Income - (IS)	23.34M	33.15M	6.28M	2.51M	-18.9M
Net Income to Common Incl Extra Items	23.34M	33.15M	6.28M	2.51M	-18.9M
Net Income to Common Excl. Extra Items	23.34M	33.15M	6.28M	2.51M	-18.9M
Per Share Items
Net EPS - Basic	0.43	0.6	0.11	0.04	-0.33
Basic EPS - Continuing Operations	0.43	0.6	0.11	0.04	-0.33
Basic Weighted Average Shares Outstanding	54.43M	55.55M	56.46M	57.38M	58.15M
Net EPS - Diluted	0.42	0.58	0.11	0.04	-0.33
Diluted EPS - Continuing Operations	0.42	0.58	0.11	0.04	-0.33
Diluted Weighted Average Shares Outstanding	55.19M	56.92M	56.98M	57.56M	58.15M
Normalized Basic EPS	0.36	0.48	0.13	-0.03	-0.32
Normalized Diluted EPS	0.36	0.47	0.12	-0.03	-0.32
Supplemental Items
EBITDA	30.1M	45.01M	9.06M	-10.94M	-32.53M
EBITA	28.72M	43.64M	7.84M	-11.86M	-33.39M
EBIT	27.24M	42.16M	6.33M	-13.95M	-40.66M
EBITDAR	32.8M	47.71M	11.66M	-8.34M	-29.88M
Total Revenues (As Reported)	248M	269M	254M	193M	199M
Effective Tax Rate - (Ratio)	26.28	21.74	44.47	60.42	17.54
Current Domestic Taxes	2.06M	2.2M	3.71M	5.02M	2.4M
Current Foreign Taxes	68K	267K	185K	91K	58K
Total Current Taxes	2.13M	2.47M	3.9M	5.12M	2.46M
Deferred Domestic Taxes	6.23M	6.72M	1.13M	-1.27M	-6.48M
Deferred Foreign Taxes	-42K	22K	3K	-15K	-3K
Total Deferred Taxes	6.19M	6.74M	1.13M	-1.28M	-6.48M
Normalized Net Income	19.78M	26.48M	7.06M	-1.54M	-18.7M
Supplemental Operating Expense Items
Marketing Expenses	12.6M	6.7M	2.6M	500K	1.9M
Selling and Marketing Expenses	12.6M	6.7M	2.6M	500K	1.9M
Research And Development Expense From Footnotes	55.58M	75.36M	85.77M	76.82M	74.43M
Net Rental Expense, Total	2.7M	2.7M	2.6M	2.6M	2.65M
Stock-Based Comp., R&D Exp. (Total)	3.8M	3.96M	3.96M	3.32M	2.96M
Stock-Based Comp., SG&A Exp. (Total)	9.56M	11.42M	12.32M	10.72M	9.47M
Total Stock-Based Compensation	13.36M	15.37M	16.28M	14.04M	12.43M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	61.03M	52.07M	135M	136M	102M
Short Term Investments	307M	381M	332M	252M	272M
Total Cash And Short Term Investments	368M	433M	467M	388M	375M
Accounts Receivable, Total	30.04M	32.47M	33.51M	34.16M	47.1M
Total Receivables	30.04M	32.47M	33.51M	34.16M	47.1M
Inventory	1.28M	1.02M	1.19M	1.36M	1.73M
Prepaid Expenses	10.03M	12M	17.73M	9.17M	15.42M
Restricted Cash	57K	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	409M	478M	519M	433M	439M
Gross Property Plant And Equipment	22.62M	21.76M	21.39M	20.32M	24.24M
Accumulated Depreciation	-8.03M	-9.38M	-10.42M	-11.18M	-11.57M
Net Property Plant And Equipment	14.6M	12.38M	10.97M	9.14M	12.68M
Other Intangibles, Total	21.56M	20.08M	18.56M	121M	114M
Deferred Tax Assets Long-Term	81.52M	74.88M	74.04M	75M	81.44M
Other Long-Term Assets, Total	6.64M	8.15M	11.38M	9.98M	9.1M
Total Assets	533M	594M	634M	648M	656M
Liabilities
Accounts Payable, Total	1.05M	925K	12.69M	7.14M	3.5M
Accrued Expenses, Total	27.99M	31.2M	30.53M	28.92M	31.32M
Current Portion of Leases	2.12M	2.31M	2.33M	2.4M	4.27M
Other Current Liabilities	34.78M	39.98M	45.88M	49.24M	60.9M
Total Current Liabilities	65.94M	74.42M	91.44M	87.7M	99.98M
Long-Term Leases	11.5M	10.06M	8.81M	7.01M	8.09M
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	2.76M	4.39M	6.8M	8.83M	9.59M
Total Liabilities	80.19M	88.86M	107M	104M	118M
Common Stock, Total	55K	56K	57K	58K	58K
Additional Paid In Capital	650M	669M	686M	700M	713M
Retained Earnings	-197M	-164M	-158M	-155M	-174M
Comprehensive Income and Other	239K	-175K	-1.19M	-30K	74K
Total Common Equity	453M	505M	527M	545M	539M
Total Equity	453M	505M	527M	545M	539M
Total Liabilities And Equity	533M	594M	634M	648M	656M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	54.88M	55.91M	56.79M	57.54M	58.32M
ECS Total Common Shares Outstanding	54.87M	55.9M	56.78M	57.53M	58.31M
Book Value / Share	8.26	9.03	9.28	9.47	9.24
Tangible Book Value	432M	485M	509M	424M	424M
Tangible Book Value Per Share	7.87	8.67	8.96	7.36	7.28
Total Debt	13.61M	12.37M	11.14M	9.4M	12.36M
Net Debt	-354M	-420M	-456M	-379M	-362M
Debt Equivalent Oper. Leases	21.6M	21.6M	20.8M	20.8M	21.19M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Work In Process, Total	66K	30K	23K	27K	-
Inventories - Finished Goods, Total	1.21M	995K	1.17M	1.33M	1.73M
Machinery, Total	6.71M	7.03M	7.58M	7.78M	8.23M
Full Time Employees	292	278	290	203	368
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	23.34M	33.15M	6.28M	2.51M	-18.9M
Depreciation & Amortization - CF	1.39M	1.36M	1.22M	920K	859K
Amortization of Goodwill and Intangible Assets - (CF)	1.48M	1.48M	1.52M	2.09M	7.27M
Depreciation & Amortization, Total	2.86M	2.84M	2.73M	3.01M	8.13M
(Gain) Loss on Sale of Investments - (CF)	-50K	1.64M	-2.96M	-8.14M	-6.99M
Stock-Based Compensation (CF)	13.36M	15.37M	16.28M	14.04M	12.43M
Other Operating Activities, Total	7.95M	8.47M	3.59M	2.13M	-3.87M
Change In Accounts Receivable	-3.77M	-2.47M	-1.09M	-707K	-13.01M
Change In Inventories	-2.88M	-2.23M	-4.48M	-771K	-29K
Change In Accounts Payable	3.76M	3.04M	11.79M	-10.98M	1.71M
Change in Other Net Operating Assets	7.2M	4.4M	-151K	11.72M	4.78M
Cash from Operations	51.78M	64.21M	31.98M	12.8M	-15.76M
Capital Expenditure	-1.8M	-552K	-679K	-101M	-4.72M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-39.7M	-76.14M	50.6M	88.99M	-12.71M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-41.5M	-76.7M	49.92M	-12.06M	-17.43M
Long-Term Debt Repaid, Total	-	-	-	-	-155K
Total Debt Repaid	-	-	-	-	-155K
Issuance of Common Stock	5.63M	3.55M	734K	-	-
Repurchase of Common Stock	-	-	-	-	-
Cash from Financing	5.63M	3.55M	734K	-	-155K
Foreign Exchange Rate Adjustments	53K	-91K	265K	47K	-163K
Net Change in Cash	15.96M	-9.02M	82.91M	792K	-33.5M
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	3.6M	2.4M
Levered Free Cash Flow	38.52M	48.22M	32.34M	-88.78M	-18.72M
Unlevered Free Cash Flow	38.52M	48.22M	32.34M	-88.78M	-18.72M
Change In Net Working Capital	-7.06M	-4.21M	-10.06M	-3.94M	9.15M
Net Debt Issued / Repaid	-	-	-	-	-155K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.35	4.68	0.64	-1.36	-3.9
Return on Total Capital	3.82	5.36	0.75	-1.6	-4.6
Return On Equity %	5.4	6.92	1.22	0.47	-3.49
Return on Common Equity	5.4	6.92	1.22	0.47	-3.49
Margin Analysis
Gross Profit Margin %	90.59	90.46	90.45	92.32	94.31
SG&A Margin	56.62	46.17	53.65	58.6	73.66
EBITDA Margin %	12.13	16.75	3.56	-5.68	-16.36
EBITA Margin %	11.57	16.24	3.08	-6.16	-16.8
EBIT Margin %	10.98	15.69	2.49	-7.24	-20.46
Income From Continuing Operations Margin %	9.4	12.34	2.47	1.3	-9.51
Net Income Margin %	9.4	12.34	2.47	1.3	-9.51
Net Avail. For Common Margin %	9.4	12.34	2.47	1.3	-9.51
Normalized Net Income Margin	7.97	9.85	2.78	-0.8	-9.41
Levered Free Cash Flow Margin	15.52	17.95	12.71	-46.08	-9.42
Unlevered Free Cash Flow Margin	15.52	17.95	12.71	-46.08	-9.42
Asset Turnover
Asset Turnover	0.49	0.48	0.41	0.3	0.3
Fixed Assets Turnover	16.75	19.92	21.78	19.16	18.22
Receivables Turnover (Average Receivables)	8.8	8.6	7.71	5.69	4.89
Inventory Turnover (Average Inventory)	19.31	22.24	21.89	11.6	7.34
Short Term Liquidity
Current Ratio	6.21	6.43	5.68	4.94	4.39
Quick Ratio	6.03	6.25	5.47	4.82	4.22
Operating Cash Flow to Current Liabilities	0.79	0.86	0.35	0.15	-0.16
Days Sales Outstanding (Average Receivables)	41.59	42.45	47.33	64.1	74.81
Days Outstanding Inventory (Average Inventory)	18.95	16.41	16.68	31.46	49.87
Average Days Payable Outstanding	21.19	14.2	101.62	241.99	166.71
Cash Conversion Cycle (Average Days)	39.35	44.67	-37.61	-146.42	-42.03
Long Term Solvency
Total Debt/Equity	3	2.45	2.11	1.73	2.3
Total Debt / Total Capital	2.92	2.39	2.07	1.7	2.24
LT Debt/Equity	2.54	1.99	1.67	1.29	1.5
Long-Term Debt / Total Capital	2.46	1.94	1.64	1.26	1.47
Total Liabilities / Total Assets	15.03	14.97	16.88	15.97	17.93
Total Debt / EBITDA	0.42	0.26	0.96	-1.13	-0.41
Net Debt / EBITDA	-10.8	-8.81	-39.08	45.42	12.13
Total Debt / (EBITDA - Capex)	0.44	0.26	1.01	-0.09	-0.36
Net Debt / (EBITDA - Capex)	-11.42	-8.92	-41.49	3.46	10.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.23	8.27	-5.32	-24.27	3.18
Gross Profit, 1 Yr. Growth %	10.9	8.12	-5.33	-22.71	5.41
EBITDA, 1 Yr. Growth %	17.12	49.51	-79.86	-220.75	197.28
EBITA, 1 Yr. Growth %	18.1	51.98	-82.02	-251.2	181.46
EBIT, 1 Yr. Growth %	19.42	54.8	-84.99	-320.45	191.43
Earnings From Cont. Operations, 1 Yr. Growth %	-79.8	42.06	-81.07	-60.02	-853.29
Net Income, 1 Yr. Growth %	-79.8	42.06	-81.07	-60.02	-853.29
Normalized Net Income, 1 Yr. Growth %	9.05	33.83	-73.33	-129.51	1.12K
Diluted EPS Before Extra, 1 Yr. Growth %	-80.09	38.1	-81.03	-63.64	-925.02
Accounts Receivable, 1 Yr. Growth %	13.92	8.09	3.22	1.92	37.9
Inventory, 1 Yr. Growth %	12.28	-19.92	16.49	13.65	27.19
Net Property, Plant and Equip., 1 Yr. Growth %	-2.98	-15.14	-11.4	-16.7	38.7
Total Assets, 1 Yr. Growth %	10.28	11.31	6.81	2.24	1.2
Tangible Book Value, 1 Yr. Growth %	11.29	12.31	4.91	-16.73	0.21
Common Equity, 1 Yr. Growth %	10.3	11.4	4.41	3.36	-1.17
Cash From Operations, 1 Yr. Growth %	12.68	24.03	-50.19	-59.98	-223.09
Capital Expenditures, 1 Yr. Growth %	76.15	-69.25	23.01	14.78K	-95.33
Levered Free Cash Flow, 1 Yr. Growth %	14.31	25.2	-32.93	-374.48	-78.91
Unlevered Free Cash Flow, 1 Yr. Growth %	14.31	25.2	-32.93	-374.48	-78.91
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	13.36	8.75	1.24	-15.33	-11.6
Gross Profit, 2 Yr. CAGR %	14.12	9.5	1.17	-14.46	-9.74
EBITDA, 2 Yr. CAGR %	10.41	32.33	-45.13	-50.69	89.46
EBITA, 2 Yr. CAGR %	11.1	33.97	-47.73	-47.87	106.3
EBIT, 2 Yr. CAGR %	11.94	35.96	-51.8	-42.48	153.46
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.78	-46.44	-48.15	-72.49	73.55
Net Income, 2 Yr. CAGR %	-3.78	-46.44	-48.15	-72.49	73.55
Normalized Net Income, 2 Yr. CAGR %	11.75	20.81	-40.25	-76.36	89.43
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.46	-47.57	-48.82	-73.74	73.21
Accounts Receivable, 2 Yr. CAGR %	2.16	10.97	5.63	2.57	18.55
Inventory, 2 Yr. CAGR %	13.48	-5.18	-3.42	15.06	20.23
Net Property, Plant and Equip., 2 Yr. CAGR %	81.78	-9.27	-13.29	-14.09	7.48
Total Assets, 2 Yr. CAGR %	26.73	10.79	9.04	4.5	1.72
Tangible Book Value, 2 Yr. CAGR %	31.18	11.8	8.54	-6.54	-8.65
Common Equity, 2 Yr. CAGR %	28.29	10.85	7.85	3.88	1.07
Cash From Operations, 2 Yr. CAGR %	31.4	18.22	-21.4	-55.35	-29.81
Capital Expenditures, 2 Yr. CAGR %	120.86	-26.4	-38.5	1.25K	163.63
Levered Free Cash Flow, 2 Yr. CAGR %	13.62	19.63	-8.36	35.68	-23.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.62	19.63	-8.36	35.68	-23.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.56	11.64	3.84	-8.1	-9.56
Gross Profit, 3 Yr. CAGR %	15.15	12.08	4.32	-7.51	-8.29
EBITDA, 3 Yr. CAGR %	29.32	22.15	-29.35	-28.63	-10.26
EBITA, 3 Yr. CAGR %	23.75	23.33	-31.41	-25.53	-8.54
EBIT, 3 Yr. CAGR %	17.24	24.71	-34.78	-19.99	-1.2
Earnings From Cont. Operations, 3 Yr. CAGR %	14.45	9.56	-62.13	-52.45	-17.08
Net Income, 3 Yr. CAGR %	14.45	9.56	-62.13	-52.45	-17.08
Normalized Net Income, 3 Yr. CAGR %	27.06	18.68	-26.98	-57.33	-12.08
Diluted EPS Before Extra, 3 Yr. CAGR %	6.27	6.51	-62.64	-54.33	-17.14
Accounts Receivable, 3 Yr. CAGR %	19.5	4.1	8.32	4.38	13.2
Inventory, 3 Yr. CAGR %	15.07	1.03	1.55	1.97	18.97
Net Property, Plant and Equip., 3 Yr. CAGR %	40.11	41.01	-9.98	-14.44	0.78
Total Assets, 3 Yr. CAGR %	37.45	21.37	9.45	6.72	3.39
Tangible Book Value, 3 Yr. CAGR %	60.04	24.56	9.45	-0.63	-4.34
Common Equity, 3 Yr. CAGR %	51.1	22.39	8.66	6.33	2.17
Cash From Operations, 3 Yr. CAGR %	196.66	28.9	-11.37	-37.24	-37.39
Capital Expenditures, 3 Yr. CAGR %	2.56	14.47	-12.66	283.25	104.47
Levered Free Cash Flow, 3 Yr. CAGR %	11.68	17.36	-1.36	32.09	-27.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	11.68	17.36	-1.36	32.09	-27.05
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.69	12.97	9.03	-0.05	-2.64
Gross Profit, 5 Yr. CAGR %	21.06	14.91	9.34	0.6	-1.55
EBITDA, 5 Yr. CAGR %	2.48	46.35	-8.23	-15.02	4.82
EBITA, 5 Yr. CAGR %	1.08	41.71	-12.34	-12.6	6.55
EBIT, 5 Yr. CAGR %	-7.48	17.82	-17.84	-8.49	12.26
Earnings From Cont. Operations, 5 Yr. CAGR %	-10.16	12.98	-16.62	-36.96	-30.38
Net Income, 5 Yr. CAGR %	-10.16	12.98	-16.62	-36.96	-30.38
Normalized Net Income, 5 Yr. CAGR %	-4.51	18.8	-6.04	-37.28	0.6
Diluted EPS Before Extra, 5 Yr. CAGR %	-14.95	6.95	-20.66	-39.16	-31
Accounts Receivable, 5 Yr. CAGR %	12.96	9.88	13.75	3.48	12.3
Inventory, 5 Yr. CAGR %	-0.22	5.64	7.29	6.42	8.65
Net Property, Plant and Equip., 5 Yr. CAGR %	26.14	19.82	15.64	15.65	-3.37
Total Assets, 5 Yr. CAGR %	20.15	23.06	25.29	14.32	6.29
Tangible Book Value, 5 Yr. CAGR %	35.57	36.18	37.02	11.04	1.82
Common Equity, 5 Yr. CAGR %	27.79	30.91	32.03	14.62	5.56
Cash From Operations, 5 Yr. CAGR %	32.98	51.29	74.39	-15.65	-19.27
Capital Expenditures, 5 Yr. CAGR %	-6.61	-17.07	-16.41	207.42	35.87
Levered Free Cash Flow, 5 Yr. CAGR %	8.22	73.49	3.18	24.37	-11.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	8.22	73.49	3.18	24.37	-11.09